Community hub
Recent from talks
Knowledge base stats:
Talk channels stats:
Members stats:
Inovalon
Inovalon is an American technology company that provides cloud-based tools for healthcare.
The company was founded in 1998 in Maryland as MedAssurant by Keith Dunleavy, MD. In June 2012, the company changed its name to Inovalon. The company publicly filed its registration statement with the Securities and Exchange Commission (SEC) on December 30, 2014 for a proposed initial public offering of its common stock and applied for listing on NASDAQ under the ticker "INOV". Inovalon went public and began trading on the NASDAQ exchange on April 12, 2015 The company's stock traded until November 2021 when the company was taken private with its acquisition by Nordic Capital and Insight Partners.
In August 2023, Inovalon's former CEO Keith Dunleavy was inducted into the Dartmouth Entrepreneur Hall of Fame.
Adam Kansler was appointed CEO of Inovalon on January 28, 2025. Kansler served as President of S&P Global Market Intelligence, also served as President of the Financial Services division and member of the executive team for IHS Markit as well as with the law firm of Proskauer LLP.
In 2012, Inovalon partnered with industry researchers to conduct a study on Hospital Readmission Rates in Medicare Advantage Plans to track readmission rates among patients enrolled in Medicare’s private comprehensive Medicare Advantage plans, and develop initial comparisons with fee-for-service (FFS) readmission rates. The study was published in The American Journal of Managed Care.
In 2013, Inovalon partnered with Walgreens and electronic health record (EHR) companies such as Allscripts, Greenway, and NeoDeck to integrate analytics platforms into the point of care. Inovalon also examined the association of socioeconomic status and other factors with underlying poor quality performance of dual-eligible members in Medicare Advantage plans, releasing a study on October 28, 2014 that was presented to Congressional representatives on October 21, 2014.
In 2014, Inovalon expanded its partnership with Walgreens to implement its "ePASS" patient assessment tool and technology platform in clinics at Walgreens locations.
In May 2015, Inovalon released an analysis of dual eligible member data, which indicated that social and demographic factors affect health-related outcomes and measurements for health plan performance, independent of plan characteristics.
Hub AI
Inovalon AI simulator
(@Inovalon_simulator)
Inovalon
Inovalon is an American technology company that provides cloud-based tools for healthcare.
The company was founded in 1998 in Maryland as MedAssurant by Keith Dunleavy, MD. In June 2012, the company changed its name to Inovalon. The company publicly filed its registration statement with the Securities and Exchange Commission (SEC) on December 30, 2014 for a proposed initial public offering of its common stock and applied for listing on NASDAQ under the ticker "INOV". Inovalon went public and began trading on the NASDAQ exchange on April 12, 2015 The company's stock traded until November 2021 when the company was taken private with its acquisition by Nordic Capital and Insight Partners.
In August 2023, Inovalon's former CEO Keith Dunleavy was inducted into the Dartmouth Entrepreneur Hall of Fame.
Adam Kansler was appointed CEO of Inovalon on January 28, 2025. Kansler served as President of S&P Global Market Intelligence, also served as President of the Financial Services division and member of the executive team for IHS Markit as well as with the law firm of Proskauer LLP.
In 2012, Inovalon partnered with industry researchers to conduct a study on Hospital Readmission Rates in Medicare Advantage Plans to track readmission rates among patients enrolled in Medicare’s private comprehensive Medicare Advantage plans, and develop initial comparisons with fee-for-service (FFS) readmission rates. The study was published in The American Journal of Managed Care.
In 2013, Inovalon partnered with Walgreens and electronic health record (EHR) companies such as Allscripts, Greenway, and NeoDeck to integrate analytics platforms into the point of care. Inovalon also examined the association of socioeconomic status and other factors with underlying poor quality performance of dual-eligible members in Medicare Advantage plans, releasing a study on October 28, 2014 that was presented to Congressional representatives on October 21, 2014.
In 2014, Inovalon expanded its partnership with Walgreens to implement its "ePASS" patient assessment tool and technology platform in clinics at Walgreens locations.
In May 2015, Inovalon released an analysis of dual eligible member data, which indicated that social and demographic factors affect health-related outcomes and measurements for health plan performance, independent of plan characteristics.